Regulatory Framework for Herbal and Natural Products in Peru – regulatory compliance pharma


Regulatory Framework for Herbal and Natural Products in Peru – regulatory compliance pharma

Published on 17/12/2025

Regulatory Framework for Herbal and Natural Products in Peru

The regulatory landscape for herbal and natural products in Peru is governed by several guidelines and standards set forth by the Direccion General de Medicamentos, Insumos y Drogas (DIGEMID). This article provides regulatory affairs teams with a comprehensive step-by-step tutorial on how to navigate the process, ensuring full regulatory compliance pharma in the development and marketing of herbal products. This framework is essential for professionals involved in pharmaceutical regulatory compliance.

Step 1: Understanding the Regulatory Environment

Before initiating any processes, it’s crucial to have a comprehensive understanding of the regulatory environment that governs herbal and natural products in Peru. This involves familiarizing yourself with the roles and responsibilities of DIGEMID through its various directives and standards.

DIGEMID operates under the Ministry of Health and is responsible for the evaluation, registration, and pharmacovigilance of medicinal products, including herbal and natural medicines. As a regulatory professional, you must understand that the classification of products dictates the regulatory requirements that apply. Herbal products are typically classified as medications,

dietary supplements, or in some cases, traditional medicines according to their composition and intended use.

Key regulations governing herbal products include:

  • Law 29459: This law establishes the framework for the regulation of medicinal products, including herbal and natural products.
  • Supreme Decree No. 17-2010: Defines the Good Manufacturing Practices (GMP) for medicines.
  • Guidelines on herbal medicine: These documents outline the specific evaluations, quality control, and compliance measures required for herbal products.

Understanding these regulations is imperative for maintaining compliance with the necessary standards. Additionally, it is advisable to stay updated on any amendments to laws or guidelines published by DIGEMID to ensure ongoing compliance.

Step 2: Preparing the Dossier for Registration

The next step in achieving regulatory compliance pharma involves the preparation of a comprehensive dossier for submission to DIGEMID. This dossier will include critical information surrounding the herbal product’s composition, manufacturing process, and therapeutic claims.

Also Read:  Food Supplement and Nutritional Product Regulation – regulatory consulting pharma

Components of a successful dossier include:

  • Product Information: This should include the name of the product, the active ingredients, and a detailed formulation. Include any specific claims about the product’s efficacy and intended use.
  • Manufacturing Process: A detailed description of the manufacturing process must be provided. This includes adherence to Good Manufacturing Practices (GMP) to ensure product quality and safety.
  • Quality Control Measures: Outline the quality control processes you have in place, including stability studies, contamination testing, and batch record reviews.
  • Safety and Efficacy Data: Provide clinical and preclinical data supporting the safety and efficacy of the herbal product. This includes toxicological studies and any previous studies or documentation available.
  • Labeling and Packaging: Include proposed labels and packaging for the product, ensuring compliance with labeling regulations under Peruvian law, including the product’s characteristics and appropriate warnings.

Thoroughly review all documentation and data to ensure completeness and compliance with DIGEMID’s requirements. Engaging with local regulatory experts can also aid in ensuring that no critical components are overlooked during the dossier preparation phase.

Step 3: Submission of the Registration Dossier

With a complete dossier in hand, the next step is to submit the registration application to DIGEMID. This step is critical and involves detailed procedures to ensure compliance and facilitate a smooth review process.

Before submission, confirm that all required fees are paid and documentation is in order. Submission must typically be done electronically via the DIGEMID’s online platform. Follow these actions closely:

  • Online Registration: Access the DIGEMID online platform and create an account if necessary. Ensure you follow the guidelines for electronic submissions.
  • Attach Required Documents: Ensure all documentation is properly compiled and converted into the required format before uploading. Utilize the digital checklist provided by DIGEMID to ensure completeness.
  • Payment of Fees: Prepare to pay any registration fees associated with the submission, as outlined by DIGEMID, to avoid delays in processing.
  • Confirmation of Submission: After submission, obtain a confirmation receipt and reference number for tracking purposes. This receipt will be crucial for any future correspondence with DIGEMID regarding your application.
Also Read:  National Drug Price Regulation and Market Monitoring – ectd regulatory affairs

Following these steps precisely will help in ensuring your submission is complete, thus elevating the chances of a successful review by regulatory authorities.

Step 4: Review Process and Communication with DIGEMID

Once your application is submitted, it enters the review process. DIGEMID will assess the dossier for completeness and compliance with established guidelines. Understanding what happens next is crucial for timely product approval.

Throughout the review process, communication with DIGEMID is key:

  • Review Timeline: Typically, DIGEMID is expected to complete the initial review within a specific timeframe (often several weeks to a few months). Preparation for potential inquiries during this review is essential.
  • Responding to Queries: Be prepared for potential requests for additional information or clarification from DIGEMID. Responding promptly and thoroughly to these inquiries is essential to avoid delays.
  • Regular Updates: Maintain contact with DIGEMID and request updates on the status of the review if the process extends beyond the expected timeline.

Having a well-managed communication strategy, including regular follow-ups and documentation of communications, will enhance your application’s chances of moving efficiently through the regulatory process. Understanding the dynamics at play will also assist in managing timelines effectively.

Step 5: Post-Approval Commitments

Once your product has been approved by DIGEMID, the responsibilities do not end there. Post-approval commitments are vital for ongoing regulatory compliance and product integrity in the market.

Key areas to focus on after approval include:

  • Labeling Compliance: Ensure that all products are accurately labeled following approved submissions. Any deviations from the approved labeling should be promptly reported to DIGEMID.
  • Pharmacovigilance: Put in place a robust pharmacovigilance system to monitor the safety of the product post-marketing. This includes reporting any adverse events or side effects associated with the herbal product.
  • Periodic Reporting: Depending on the regulations, you may be required to provide periodic reports to DIGEMID summarizing product performance, safety data, and any changes in manufacturing or formulation.
  • Compliance Inspections: Be prepared for inspections or audits by DIGEMID to ensure ongoing compliance with quality and safety standards. Regular internal quality audits can be beneficial in maintaining compliance.
Also Read:  Digital Health Technologies and Software-as-a-Medical-Device (SaMD) – fda regulatory affairs

By actively managing these factors, your organization can sustain regulatory compliance and build a trustworthy reputation in the herbal product market in Peru.

Conclusion

Implementing a regulatory compliance pharma strategy for herbal and natural products in Peru requires a detailed understanding of the regulatory framework established by DIGEMID. By following this step-by-step tutorial, regulatory affairs teams can navigate the complexities of the registration process effectively.

From comprehending the regulatory environment to the post-approval commitments, each step outlined provides critical insights and actionable guidelines to ensure compliance. Engaging regulatory experts at each stage can further solidify your product’s standing in the marketplace, ultimately promoting safe and effective herbal products for consumers.

For more information, you can refer to the DIGEMID official site and stay informed about any updates in the regulatory landscape for herbal and natural products.